Rudi Fasan

Rudi Fasan

Assistant Professor of Chemistry


Ph.D. 2005, University of Zurich, Switzerland

Bioorganic chemistry, Chemo-enzymatic synthesis, and Chemical biology

The research interests of our group lie in the areas of bioorganic chemistry, chemical biology, and biomolecular engineering and evolution. Our laboratory integrates methods and principles of organic chemistry, molecular biology, and molecular evolution to develop novel chemo-biosynthetic and chemo-enzymatic approaches to the discovery of biologically active molecules. Our goal is to investigate and apply these methodologies toward the development of chemical agents useful for probing cell signaling pathways and controlling biomolecular interactions implicated in cancer development and HIV infection.

A major project involves the design and development of new strategies to direct the synthesis, diversification, and evolution of macrocyclic peptide-based molecules as potent and selective modulators of protein-protein interactions (PPIs). PPIs are implicated in all cellular processes from signal transduction to gene regulation, cell proliferation and apoptosis. Chemical agents capable of targeting PPIs with high potency and selectivity can provide invaluable tools for the study of complex cellular pathways and useful starting points for development of new therapeutics, but the development of such compounds remains a fundamental problem in chemical biology and drug discovery. Our group has pioneered methods to generate Macrocyclic Organo-Peptide Hybrids (MOrPHs) via the modular assembly of synthetic organic moieties with genetically encoded polypeptide precursors. These molecules constitute attractive molecular scaffolds to mediate specific and high-affinity recognition of a target protein as they combine a high degree of chemical complexity with a compact and conformationally rigid architecture. In addition, the MOrPH approach enables to couple the versatility of chemical synthesis with the advantages of genetic encoding and power of genetic mutagenesis, providing unique opportunities for the creation and screening of highly diverse chemical libraries and the molecular evolution of organo-peptide macrocycles with tailored protein-binding selectivity. Our group is exploring the potential of this new class of macrocyclic structures to tackle challenging molecular recognition problems, such as the selective and efficient disruption of protein-protein and protein-DNA complexes of therapeutic relevance and the specific recognition of structural homologues and post-translational isoforms of human proteins. An integral component of these studies is the application of a variety of biophysical techniques (e.g. Surface Plasmon Resonance, NMR and fluorescence spectroscopy) and biological assays for the characterization of the conformational and binding properties and biological activity of these compounds.

Another area of interest is the implementation and investigation of new chemo-enzymatic methodologies, involving cytochrome P450 enzymes, to enable the late-stage transformation of aliphatic C―H bonds in complex molecules and in particular in bioactive natural products. Our group is developing systematic approaches to evaluate and predict the reactivity of P450 monooxygenases via application of high-throughput screening methods and computational tools. We are also exploring new protein engineering and chemical approaches to enable rapid fine-tuning of the regio- and stereoselectivity of these enzymes. The ultimate goal of these studies is to develop efficient and systematic approaches to expedite the development of P450 oxidation catalysts with tailor-made activity and regio- and stereoselectivity for synthetic applications. The scope and synthetic value of these methodologies is being investigated through the synthesis and functional elaboration of complex natural product scaffolds of medical interest via P450-mediated synthesis.

All our projects involve the synergistic integration of rational design, chemical synthesis, protein chemistry, and molecular evolution methods toward the development of enabling molecular discovery platforms of practical and broad utility. Members of the Fasan group have thus the opportunity to receive training in these areas and conduct interdisciplinary research at the intersection of chemistry, biology, and biophysics.

Selected Publications

Fasan, R.   “Tuning P450 Enzymes as Oxidation Catalysts,”  ACS Catal.  2012Just Accepted Manuscript.
Satyanarayana, M., Vitali, F., Frost, J. R., Fasan, R.   “Diverse organo-peptide macrocycles via a fast and catalyst-free oxime/intein-mediated dual ligation,”  Chem. Comm.  2012481461-1463.
Smith, J. M., Vitali, F., Archer, S. A., Fasan, R.  “Modular assembly of macrocyclic organo-peptide hybrids using synthetic and genetically encoded precursors,”  Angew. Chem. Int. Ed. Engl.  201150(22)5075-80.
Zhang, K., El Damaty, S., Fasan, R.  “P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity,”  J. Am. Chem. Soc  2011133(10)3242-3245.
Fasan, R., Crook, N. C., Peters, M. W., Meinhold, P., Buelter, T., Landwehr, M., Cirino, P. C., Arnold, F. H.  “Improved product-per-glucose yields in P450-dependent biotransformations using engineered E. coli,”  Biotechnol. Bioeng.  2011108500-510.
Rentmeister, A., Arnold, F. H., Fasan, R.  "Chemo-enzymatic fluorination of unactivated organic compounds,"  Nat. Chem. Biol.  2009526-28.
Fasan, R., Meharenna, Y. T., Snow, C. D., Poulos, T. L., Arnold, F. H.  "Evolutionary history of a specialized P450 propane monooxygenase,"  J. Mol. Biol.  2008383(5)1069-1080.
Fasan, R., Chen, M. M., Crook, N. C., Arnold, F. H.  "Engineered alkane-hydroxylating cytochrome P450BM3 exhibiting native-like catalytic properties,"  Angew. Chem. Int. Ed. Engl.  2007468414-8418.
Fasan, R., Dias, R. L., Moehle, K., Zerbe, O., Mittl, P. R., Grütter, M. G., Robinson, J. A.  "Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction,"  ChemBiochem  20067515-526.
Dias, R. L., Fasan, R., Moehle, K., Renard, A., Obrecht, D., Robinson, J. A.  "Protein ligand design: from phage display to synthetic protein epitope mimetics in human antibody Fc-binding peptidomimetics,"  J. Am. Chem. Soc.   20061282726-2732.
Fasan, R., Dias, R. L., Moehle, K., Zerbe, O., Vrijbloed, J. W., Robinson, J. A.  "Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction,"  Angew. Chem. Int. Ed. Engl.  2004432109-2112.
Back to Faculty Listing

Professor Fasan's Contact Information...

Office: Hutchison 416
Phone: (585) 273-3504


You may also be interested in...